tretinoin · Valeant Pharms North · NDA 019963, 021108
Renova
Earliest generic entry, as listed
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- 26 Oct 2026Generic approved · 021108-00115 Sep 2026
Products covered · 2
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 019963 · 001 · RLD · discontinued | cream, topical | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | open |
| 021108 · 001 · RLD | cream, topical | 0.02% | open |